冠状动脉支架的演变:创新,抗血栓策略和未来方向
1Cardiovascular Research Unit, The University of Sheffield, Sheffield, England, UK w.parker@sheffield.ac.uk.
Heart (British Cardiac Society)
|March 4, 2025
概括
药物排泄支架 (DES) 和抗血栓治疗的进步改善了冠状动脉综合征患者的治疗结果. 较早地将双抗血小板治疗 (DAPT) 降级为单一治疗通常是合适的,以平衡缺血和出血风险.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 药物排泄支架 (DES) 在急性和慢性冠状动脉综合征的皮肤通冠状动脉干预 (PCI) 中至关重要.
- 不断发展的DES平台具有薄设计,生物相容/可生物吸收的聚合物或无聚合物选项,提高了交付能力和安全性.
- 支架植入技术和抗血栓治疗方法已经显著进步,改善了患者的治疗结果,降低了血栓风险.
研究的目的:
- 审查DES技术和PCI的抗血栓策略的最新进展.
- 讨论支架植入,病变准备和术后优化等不断变化的领域.
- 评估针对特定患者群体的双重抗血小板治疗 (DAPT) 早期降级的理由和证据.
主要方法:
- 对DES和抗血栓剂的当前文献和临床试验数据的审查.
- 分析干预性心脏病实践的趋势,包括冠心内成像和病变准备.
- 评估指导方针和证据,支持对DAPT持续时间和降级战略进行调整.
主要成果:
- 现代的DES,包括超薄的杆变体,提供了更好的性能,尽管在复杂的病变中仍然存在挑战.
- 新的抗血栓剂可提供可靠的P2Y12抑制,有助于减少血栓事件.
- 证据支持在特定患者中更早地将DAPT降级为单一疗法 (例如蒂卡格勒勒),平衡缺血和出血风险.
结论:
- 优化的DES设计,植入技术和抗血栓治疗方案显著降低了PCI中的血栓风险.
- 较早的DAPT缓解是许多患者的合理策略,以个人缺血和出血风险概况为指导.
- 未来的方向包括'不留任何东西'的策略和对心血管风险因素的进一步药理优化.
更多相关视频
06:55Fabrication of Small Caliber Stent-grafts Using Electrospinning and Balloon Expandable Bare Metal Stents
Published on: October 26, 2016
8.9K
12:30Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers
Published on: August 12, 2014
9.8K
相关概念视频
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
454
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
454
01:17Ischemic Heart Disease: Overview
1.1K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.1K
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.1K
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
437
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
437
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
590
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
590
01:16Antianginal Drugs: Nitrates and β-Blockers
490
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
490